An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311

NCT03531710 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
34
Enrollment
INDUSTRY
Sponsor class

Stopped United Neuroscience has decided to terminate V203-AD-EXT study based on a treatment assignment error

Conditions

Interventions

Sponsor

United Neuroscience Ltd.